Target intelligence / Profile preview

Ribosomal protein L28 pseudogene 2 (RPL28P2)

Target
RPL28P2
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L28 pseudogene 2 (RPL28P2) is a processed pseudogene of the RPL28 gene, which normally encodes a component of the large 60S ribosomal subunit involved in protein synthesis. Pseudogenes like RPL28P2 do not encode functional proteins and are generally considered nonfunctional genomic elements. They typically arise through retrotransposition or duplication events and are dispersed throughout the genome. RPL28P2 has no known therapeutic or diagnostic use and is not involved in any identified biological processes or disease roles[1][9][13]. The true functional gene in this family is RPL28 (60S ribosomal protein L28), which codes for a cytoplasmic ribosomal protein with a role in protein synthesis[4][7]. The pseudogene RPL28P2 itself does not code for any active ribosomal protein, contribute to the ribosome structure, or possess any receptor, enzyme, transporter, or regulatory activity[1][9]. Pseudogenes can sometimes be transcribed, but there is no evidence that RPL28P2 transcripts are biologically functional. Multiple processed pseudogenes exist for ribosomal proteins, including RPL28, but these are considered genetic byproducts or "genomic fossils" without clinical or functional relevance[1][9][13].

Other names
RPL28P2RPL28_1_335RPL28_1_335_RPL28 pseudogene 2

Beyond the preview

Go deeper on Ribosomal protein L28 pseudogene 2 (RPL28P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L28 pseudogene 2 (RPL28P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call